Prudential PLC Sells 1,958 Shares of Intuitive Surgical, Inc. $ISRG

Prudential PLC lessened its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.7% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 51,636 shares of the medical equipment provider’s stock after selling 1,958 shares during the quarter. Prudential PLC’s holdings in Intuitive Surgical were worth $29,245,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently bought and sold shares of the company. Draper Asset Management LLC boosted its position in Intuitive Surgical by 41.9% during the fourth quarter. Draper Asset Management LLC now owns 5,029 shares of the medical equipment provider’s stock valued at $2,848,000 after purchasing an additional 1,485 shares in the last quarter. Procyon Advisors LLC raised its stake in Intuitive Surgical by 787.8% in the fourth quarter. Procyon Advisors LLC now owns 4,794 shares of the medical equipment provider’s stock valued at $2,715,000 after buying an additional 4,254 shares during the last quarter. Oppenheimer Asset Management Inc. raised its stake in Intuitive Surgical by 29.3% in the fourth quarter. Oppenheimer Asset Management Inc. now owns 71,077 shares of the medical equipment provider’s stock valued at $40,255,000 after buying an additional 16,119 shares during the last quarter. Vanguard Group Inc. raised its stake in Intuitive Surgical by 0.8% in the third quarter. Vanguard Group Inc. now owns 33,599,661 shares of the medical equipment provider’s stock valued at $15,026,776,000 after buying an additional 263,828 shares during the last quarter. Finally, Bessemer Group Inc. increased its holdings in shares of Intuitive Surgical by 22.8% in the third quarter. Bessemer Group Inc. now owns 967,778 shares of the medical equipment provider’s stock valued at $432,821,000 after purchasing an additional 179,450 shares during the period. Institutional investors own 83.64% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on ISRG shares. Evercore cut their price objective on Intuitive Surgical from $550.00 to $480.00 and set a “neutral” rating on the stock in a report on Monday, April 6th. Weiss Ratings reissued a “hold (c)” rating on shares of Intuitive Surgical in a report on Tuesday, May 19th. Truist Financial cut their price objective on Intuitive Surgical from $650.00 to $580.00 and set a “buy” rating on the stock in a report on Wednesday, April 15th. Citigroup raised Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 price objective on the stock in a report on Wednesday, March 11th. Finally, Jefferies Financial Group cut their price objective on Intuitive Surgical from $560.00 to $515.00 and set a “hold” rating on the stock in a report on Wednesday, April 22nd. Nineteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $573.63.

Intuitive Surgical News Summary

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Recent commentary highlighted Intuitive Surgical’s AI-driven digital roadmap and the long-term growth potential of its da Vinci ecosystem, which could support future revenue from surgical data, software, and robotics adoption.
• Neutral Sentiment: Intuitive Surgical promoted Taylor Patton to Chief Commercial and Marketing Officer, signaling a sharper focus on global growth and commercial execution, but this is more of a strategic leadership update than an immediate earnings catalyst. Article Title
• Neutral Sentiment: Analysts remain divided overall: some firms maintain bullish ratings and high price targets, while others have trimmed targets or kept a cautious stance, reflecting uncertainty about how much growth is already priced into the stock.
• Negative Sentiment: Medtronic is seeking clearance for more indications for its Hugo surgical robot, which could intensify competition in major robotic surgery markets and challenge Intuitive Surgical’s leadership position. Article Title
• Negative Sentiment: Investor concern remains elevated after multiple pieces noted that ISRG has fallen sharply in 2026, with commentary questioning whether the recent weakness reflects a broader rerating after a strong prior run.
• Negative Sentiment: SVP Iman Jeddi sold 5,625 shares in a pre-arranged 10b5-1 transaction, which may still weigh on sentiment because insider selling can be read as a lack of near-term confidence. Article Title

Insider Buying and Selling

In other Intuitive Surgical news, SVP Iman Jeddi sold 5,625 shares of the firm’s stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $420.55, for a total value of $2,365,593.75. Following the sale, the senior vice president directly owned 6,463 shares of the company’s stock, valued at approximately $2,718,014.65. This trade represents a 46.53% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the firm’s stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $446.95, for a total value of $178,780.00. Following the completion of the sale, the executive vice president directly owned 6,120 shares in the company, valued at approximately $2,735,334. The trade was a 6.13% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 7,448 shares of company stock valued at $3,224,404 in the last 90 days. Corporate insiders own 0.60% of the company’s stock.

Intuitive Surgical Stock Up 2.8%

Intuitive Surgical stock opened at $418.82 on Friday. The firm has a market cap of $148.33 billion, a price-to-earnings ratio of 50.77, a price-to-earnings-growth ratio of 3.25 and a beta of 1.46. Intuitive Surgical, Inc. has a 52 week low of $396.68 and a 52 week high of $603.88. The business’s 50-day moving average price is $448.20 and its 200 day moving average price is $501.58.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 EPS for the quarter, topping the consensus estimate of $2.08 by $0.42. The firm had revenue of $2.77 billion for the quarter, compared to analyst estimates of $2.62 billion. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.Intuitive Surgical’s revenue for the quarter was up 23.0% compared to the same quarter last year. During the same period last year, the company earned $1.81 earnings per share. Equities analysts expect that Intuitive Surgical, Inc. will post 8.57 EPS for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.